Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Cyanotech supplement

This article was originally published in The Tan Sheet

Executive Summary

Petition seeking amendment of food additive regs "to provide for the safe use of Haematococcus algae astaxanthin as a nutrient supplement" filed by Kailua-Kona, Hawaii based firm, FDA says in Federal Register notice April 11. Cyanotech's microalgae-based products include BioAstin, which contains Haematococcus algae astaxanthin...

You may also be interested in...

Cyanotech petition withdrawn

Request to amend food additive regs to "provide for safe use of Haematococcus algae astaxanthin as a nutrient supplement" withdrawn by Kailua-Kona, Hawaii-based firm, FDA says in June 27 Federal Register. Unable to comply with agency's 30-day deadline to submit supporting safety data, Cyanotech withdrew filing so it could furnish additional test data on astaxanthin levels in foods such as energy bars. Firm says it plans to resubmit petition within a month. Original submission was filed with FDA in April (1"The Tan Sheet" April 15, 2002, In Brief)...

Abbott Launches Five-Minute POC Rapid COVID-19 Test

Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.

In A Bizarre Move, Trump Orders GM To Make Ventilators – Even Though The Auto Giant Already Is

President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts